Result of AGM & Issue of Options
4basebio PLC announced that all resolutions were passed at its Annual General Meeting. The company also disclosed the issuance of 360,000 options to employees and a consultant on June 29, 2026, with exercise prices based on market closing prices from May 1 and June 29, 2026. Employee options vest annually over four years from May 1, 2026, while the consultant's options are immediately vested.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
Result of AGM
Issue of Options
CAMBRIDGE, UK - 30 June 2026
-
4basebio PLC (AIM: 4BB), a company pioneering an enzymatically-produced DNA technology serving the next generation genetic medicines markets, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.
Issue of Options
Further to the above, on 29 June 2026, the Company granted to employees and a consultant in aggregate 360,000 options over new ordinary shares in the Company. The option exercise prices are based on the mid-market closing price on 1 May 2026 and 29 June 2026 for UK and US employees respectively, subject to their granting criteria. The options to employees vest annually in equal tranches over four years from the vesting start date of 1 May 2026 and the options to the consultant are immediately vested on grant.
.
4369568_0.png
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.